NO20024656D0 - Nukle¶r faktor KB-induserende faktor - Google Patents
Nukle¶r faktor KB-induserende faktorInfo
- Publication number
- NO20024656D0 NO20024656D0 NO20024656A NO20024656A NO20024656D0 NO 20024656 D0 NO20024656 D0 NO 20024656D0 NO 20024656 A NO20024656 A NO 20024656A NO 20024656 A NO20024656 A NO 20024656A NO 20024656 D0 NO20024656 D0 NO 20024656D0
- Authority
- NO
- Norway
- Prior art keywords
- nfif
- polypeptides
- methods
- factor
- nfkb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19390500P | 2000-03-31 | 2000-03-31 | |
GBGB0018307.9A GB0018307D0 (en) | 2000-07-26 | 2000-07-26 | Polypeptides |
PCT/US2001/010719 WO2001074900A2 (en) | 2000-03-31 | 2001-04-02 | Nuclear factor kb inducing factor |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024656D0 true NO20024656D0 (no) | 2002-09-27 |
NO20024656L NO20024656L (no) | 2002-11-28 |
NO331972B1 NO331972B1 (no) | 2012-05-14 |
Family
ID=26244722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024656A NO331972B1 (no) | 2000-03-31 | 2002-09-27 | Nukleinsyre kodende for Nukleaer faktor kB-induserende faktor, protein, ekspresjonsvektor, celle, sammensetning, fremgangsmate for a evaluere forbindelser, anvendelse for fremstilling av et medikament, samt farmasoytisk sammensetning. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1290023B1 (no) |
JP (1) | JP4750999B2 (no) |
KR (1) | KR100811571B1 (no) |
AT (1) | ATE486089T1 (no) |
AU (1) | AU4793101A (no) |
CA (1) | CA2404688C (no) |
DE (1) | DE60143354D1 (no) |
DK (1) | DK1290023T3 (no) |
HK (1) | HK1053312A1 (no) |
IL (3) | IL151987A0 (no) |
MX (1) | MXPA02009481A (no) |
NO (1) | NO331972B1 (no) |
NZ (1) | NZ521786A (no) |
PT (1) | PT1290023E (no) |
WO (1) | WO2001074900A2 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117534753B (zh) * | 2023-12-07 | 2024-05-10 | 北京博奥森生物技术有限公司 | 一种诱导高性能NF-κB多克隆抗体多肽及其应用 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0467349B1 (en) | 1983-10-20 | 2000-12-27 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
CA2108144A1 (en) | 1991-03-06 | 1992-09-07 | Jack A. Roth | Methods and compositions for the selective inhibition of gene expression |
AU3129993A (en) | 1991-11-08 | 1993-06-07 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
EP0642589A4 (en) | 1992-05-11 | 1997-05-21 | Ribozyme Pharm Inc | METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION. |
DE69334095T2 (de) | 1992-07-17 | 2007-04-12 | Dana-Farber Cancer Institute, Boston | Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen |
EP0786522A2 (en) | 1992-07-17 | 1997-07-30 | Ribozyme Pharmaceuticals, Inc. | Enzymatic RNA molecules for treatment of stenotic conditions |
EP0905253A3 (en) | 1992-12-03 | 2000-11-02 | Genzyme Corporation | Adenoviral vector deleted of all E4-ORF except ORF6 |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
FR2706486B1 (fr) | 1993-06-16 | 1995-09-01 | Rhone Poulenc Rorer Sa | Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques. |
DE69435108D1 (de) | 1993-07-13 | 2008-08-14 | Centelion | Defekte adenovirus-vektoren und deren verwendung in der gentherapie |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
EP0904366A1 (en) * | 1996-04-01 | 1999-03-31 | Genentech, Inc. | Apo-2li and apo-3 apoptosis polypeptides |
US6235512B1 (en) * | 1997-07-01 | 2001-05-22 | Tularik Inc. | IKK-α proteins, nucleic acids and methods |
US7122373B1 (en) * | 1998-05-14 | 2006-10-17 | Nuvelo, Inc. | Human genes and gene expression products V |
US6132964A (en) * | 1998-02-06 | 2000-10-17 | Incyte Pharmaceuticals, Inc. | Hydrolase enzymes |
GB9814036D0 (en) * | 1998-06-29 | 1998-08-26 | Univ Dundee | Materials and methods relating to the induction of apoptosis in target cells |
US6077672A (en) * | 1998-08-28 | 2000-06-20 | Isis Pharmaceuticals Inc. | Antisense modulation of TRADD expression |
CN1302897A (zh) * | 1999-10-28 | 2001-07-11 | 上海博容基因开发有限公司 | 一种新的多肽——人酸性鞘磷酯酶相似的磷酸二酯酶21和编码这种多肽的多核苷酸 |
WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2001077389A2 (en) * | 2000-04-05 | 2001-10-18 | Incyte Genomics, Inc. | Genes expressed in foam cell differentiation |
WO2001094629A2 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2001
- 2001-04-02 MX MXPA02009481A patent/MXPA02009481A/es active IP Right Grant
- 2001-04-02 JP JP2001572589A patent/JP4750999B2/ja not_active Expired - Fee Related
- 2001-04-02 DE DE60143354T patent/DE60143354D1/de not_active Expired - Lifetime
- 2001-04-02 DK DK01920925.3T patent/DK1290023T3/da active
- 2001-04-02 EP EP01920925A patent/EP1290023B1/en not_active Expired - Lifetime
- 2001-04-02 NZ NZ521786A patent/NZ521786A/en not_active IP Right Cessation
- 2001-04-02 IL IL15198701A patent/IL151987A0/xx unknown
- 2001-04-02 PT PT01920925T patent/PT1290023E/pt unknown
- 2001-04-02 KR KR1020027013083A patent/KR100811571B1/ko not_active IP Right Cessation
- 2001-04-02 CA CA2404688A patent/CA2404688C/en not_active Expired - Fee Related
- 2001-04-02 AT AT01920925T patent/ATE486089T1/de active
- 2001-04-02 AU AU4793101A patent/AU4793101A/xx not_active Withdrawn
- 2001-04-02 WO PCT/US2001/010719 patent/WO2001074900A2/en active Application Filing
-
2002
- 2002-09-27 NO NO20024656A patent/NO331972B1/no not_active IP Right Cessation
- 2002-09-29 IL IL151987A patent/IL151987A/en not_active IP Right Cessation
-
2003
- 2003-08-01 HK HK03105529.6A patent/HK1053312A1/xx not_active IP Right Cessation
-
2009
- 2009-04-16 IL IL198132A patent/IL198132A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60143354D1 (de) | 2010-12-09 |
IL151987A0 (en) | 2003-04-10 |
CA2404688C (en) | 2012-07-31 |
JP2003529360A (ja) | 2003-10-07 |
DK1290023T3 (da) | 2011-02-14 |
KR100811571B1 (ko) | 2008-03-10 |
AU4793101A (en) | 2001-10-15 |
MXPA02009481A (es) | 2004-05-14 |
WO2001074900A2 (en) | 2001-10-11 |
WO2001074900A9 (en) | 2003-03-06 |
NO20024656L (no) | 2002-11-28 |
JP4750999B2 (ja) | 2011-08-17 |
IL198132A0 (en) | 2011-08-01 |
EP1290023A2 (en) | 2003-03-12 |
PT1290023E (pt) | 2011-01-05 |
KR20020087459A (ko) | 2002-11-22 |
WO2001074900A3 (en) | 2002-05-02 |
HK1053312A1 (en) | 2003-10-17 |
ATE486089T1 (de) | 2010-11-15 |
NO331972B1 (no) | 2012-05-14 |
IL151987A (en) | 2010-12-30 |
EP1290023B1 (en) | 2010-10-27 |
NZ521786A (en) | 2004-07-30 |
CA2404688A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120241T1 (el) | Χρησιμοποιηση εψιδινης για την παρασκευη ενος φαρμακου για τη θεραπεια διαταραχων της ομοιοστασης του σιδηρου | |
SE9800836D0 (sv) | New Compounds | |
TR200103233T2 (tr) | Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri. | |
ATE232396T1 (de) | Oxydiertes thymosin beta 4 | |
DE60003148D1 (de) | Bestimmung der Cachezeit | |
ITMI20010684A0 (it) | Dispositivo e procedimento di controllo della entita' del grasso intra-addominale | |
FR2834889B1 (fr) | Forme pharmaceutique solide orodispersible | |
ITMI20011057A0 (it) | Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi | |
ITNA20000036A0 (it) | Nuovi approcci terapeutici per il trattamento della forfora. | |
DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid | |
ATE306924T1 (de) | 2-substituierte 1-arylpiperazine als tachykinin- antagonisten und/oder serotonin-wiederaufnahme- hemmer | |
ATE483699T1 (de) | Neue 2-arylthiazolverbindungen als ppar-alpha und gamma agonisten | |
NO20024656D0 (no) | Nukle¶r faktor KB-induserende faktor | |
EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
DE60213798D1 (de) | Carbolinderivate als pdev inhibitoren | |
NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
DE60017916D1 (de) | Messung der magensäure von tieren wie kühe | |
AP2009004857A0 (en) | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures,which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof | |
BR0109721A (pt) | Fator de indução do fator kb nuclear | |
ITLI20020003A1 (it) | Custodia per totanaia e simili idonea alla sicurezza antinfortunistica del pescatore e ad un uso facile di attrezzi da pesca | |
DE50208267D1 (de) | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit | |
DE60208788D1 (de) | Prüfung der arzneistoffempfindlichkeit von viren | |
IT1294932B1 (it) | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie | |
IT1318534B1 (it) | Metodo per misurare caratteristiche meccaniche totali e regionali delsistema respiratorio umano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |